Medtronic Plc Stock Analysis

MDT Stock  USD 91.22  0.65  0.71%   
Medtronic PLC is undervalued with Real Value of 100.33 and Target Price of 95.56. The main objective of Medtronic PLC stock analysis is to determine its intrinsic value, which is an estimate of what Medtronic PLC is worth, separate from its market price. There are two main types of Medtronic PLC's stock analysis: fundamental analysis and technical analysis.
The Medtronic PLC stock is traded in the USA on New York Stock Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Medtronic PLC is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. Medtronic Stock trading window is adjusted to America/New York timezone.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.
For more information on how to buy Medtronic Stock please use our How to Invest in Medtronic PLC guide.

Medtronic Stock Analysis Notes

About 86.0% of the company shares are owned by institutional investors. The book value of Medtronic PLC was now reported as 38.49. The company has Price/Earnings To Growth (PEG) ratio of 1.58. Medtronic PLC last dividend was issued on the 28th of March 2025. The entity had 2:1 split on the 27th of September 1999. Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. Medtronic operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 95000 people. To find out more about Medtronic PLC contact Omar Ishrak at 353 1 438 1700 or learn more at https://www.medtronic.com.

Medtronic PLC Quarterly Total Revenue

8.29 Billion

Medtronic PLC Investment Alerts

Over 86.0% of the company shares are owned by institutional investors
Latest headline from thelincolnianonline.com: Disposition of 1540 shares by Gary Corona of Medtronic PLC at 80.0 subject to Rule 16b-3

Medtronic PLC Upcoming and Recent Events

20th of February 2024
Upcoming Quarterly Report
View
23rd of May 2024
Next Financial Report
View
31st of January 2024
Next Fiscal Quarter End
View
23rd of May 2024
Next Fiscal Year End
View
31st of October 2023
Last Quarter Report
View
30th of April 2023
Last Financial Announcement
View

Medtronic Largest EPS Surprises

Earnings surprises can significantly impact Medtronic PLC's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2020-05-21
2020-04-300.680.58-0.114 
2021-02-23
2021-01-311.151.290.1412 
2020-11-24
2020-10-310.81.020.2227 
View All Earnings Estimates

Medtronic PLC Environmental, Social, and Governance (ESG) Scores

Medtronic PLC's ESG score is a quantitative measure that evaluates Medtronic PLC's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Medtronic PLC's operations that may have significant financial implications and affect Medtronic PLC's stock price as well as guide investors towards more socially responsible investments.

Medtronic PLC Thematic Classifications

In addition to having Medtronic PLC stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Giant Impact Idea
Giant Impact
Public companies with mega capitalization
Obamacare Repeal Idea
Obamacare Repeal
Large healthcare related equities associated with Obamacare
Dividend Beast Idea
Dividend Beast
Solid, dividend-paying stocks and ETFs

Medtronic Stock Institutional Investors

Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Franklin Resources Inc2024-12-31
16.3 M
Amvescap Plc.2024-12-31
15.4 M
Norges Bank2024-12-31
14.6 M
Royal Bank Of Canada2024-12-31
13.1 M
Northern Trust Corp2024-12-31
12.8 M
Wellington Management Company Llp2024-12-31
12.4 M
Ameriprise Financial Inc2024-12-31
12 M
Arnhold & S. Bleichroeder Advisers, Llc2024-12-31
9.8 M
American Century Companies Inc2024-12-31
9.4 M
Vanguard Group Inc2024-12-31
124.2 M
Blackrock Inc2024-12-31
114.2 M
Note, although Medtronic PLC's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Medtronic Market Capitalization

The company currently falls under 'Mega-Cap' category with a total capitalization of 116.99 B.

Medtronic Profitablity

The company has Net Profit Margin of 0.13 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.22 %, which entails that for every 100 dollars of revenue, it generated $0.22 of operating income.
Last ReportedProjected for Next Year
Return On Tangible Assets 0.11  0.18 
Return On Capital Employed 0.05  0.05 
Return On Assets 0.04  0.04 
Return On Equity 0.07  0.07 

Management Efficiency

Medtronic PLC has Return on Asset of 0.0466 % which means that on every $100 spent on assets, it made $0.0466 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.0844 %, implying that it generated $0.0844 on every 100 dollars invested. Medtronic PLC's management efficiency ratios could be used to measure how well Medtronic PLC manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.18 in 2025, whereas Return On Capital Employed is likely to drop 0.05 in 2025. Total Current Liabilities is likely to gain to about 13 B in 2025. Liabilities And Stockholders Equity is likely to gain to about 108.7 B in 2025
Last ReportedProjected for Next Year
Book Value Per Share 38.37  40.29 
Tangible Book Value Per Share(6.02)(5.72)
Enterprise Value Over EBITDA 24.28  12.54 
Price Book Value Ratio 3.42  5.46 
Enterprise Value Multiple 24.28  12.54 
Price Fair Value 3.42  5.46 
Enterprise Value179 B187.9 B
Management at Medtronic PLC focuses on leveraging technology and optimizing operations. We evaluate the impact of these focuses on the company's financial health and stock performance.
Dividend Yield
0.0307
Operating Margin
0.2195
Profit Margin
0.1283
Forward Dividend Yield
0.0307
Beta
0.823

Technical Drivers

As of the 21st of March, Medtronic PLC secures the Mean Deviation of 1.03, risk adjusted performance of 0.1039, and Downside Deviation of 1.88. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medtronic PLC, as well as the relationship between them.

Medtronic PLC Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Medtronic PLC middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Medtronic PLC. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Medtronic PLC Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Medtronic PLC insiders, such as employees or executives, is commonly permitted as long as it does not rely on Medtronic PLC's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Medtronic PLC insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Medtronic PLC Outstanding Bonds

Medtronic PLC issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Medtronic PLC uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Medtronic bonds can be classified according to their maturity, which is the date when Medtronic PLC has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Medtronic PLC Predictive Daily Indicators

Medtronic PLC intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Medtronic PLC stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Medtronic PLC Corporate Filings

8K
17th of March 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
10th of March 2025
Other Reports
ViewVerify
F3
5th of March 2025
The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock
ViewVerify
10Q
25th of February 2025
Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations
ViewVerify
8K
18th of February 2025
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
14th of February 2025
Other Reports
ViewVerify
F4
28th of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
F4
27th of January 2025
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Medtronic PLC Forecast Models

Medtronic PLC's time-series forecasting models are one of many Medtronic PLC's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Medtronic PLC's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Medtronic Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Medtronic PLC prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medtronic shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Medtronic PLC. By using and applying Medtronic Stock analysis, traders can create a robust methodology for identifying Medtronic entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin 0.13  0.24 
Operating Profit Margin 0.15  0.25 
Net Profit Margin 0.12  0.18 
Gross Profit Margin 0.65  0.80 

Current Medtronic Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Medtronic analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Medtronic analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
95.56Buy32Odds
Medtronic PLC current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Medtronic analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Medtronic stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Medtronic PLC, talking to its executives and customers, or listening to Medtronic conference calls.
Medtronic Analyst Advice Details

Medtronic Stock Analysis Indicators

Medtronic PLC stock analysis indicators help investors evaluate how Medtronic PLC stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Medtronic PLC shares will generate the highest return on investment. By understating and applying Medtronic PLC stock analysis, traders can identify Medtronic PLC position entry and exit signals to maximize returns.
Begin Period Cash Flow1.5 B
Long Term Debt23.9 B
Common Stock Shares Outstanding1.3 B
Total Stockholder Equity50.2 B
Tax Provision1.1 B
Quarterly Earnings Growth Y O Y0.019
Property Plant And Equipment Net7.1 B
Cash And Short Term InvestmentsB
Cash1.3 B
Accounts Payable2.4 B
Net Debt24.8 B
50 Day M A90.0846
Total Current Liabilities10.8 B
Other Operating Expenses27.2 B
Non Current Assets Total68 B
Forward Price Earnings15.7233
Non Currrent Assets Other5.1 B
Stock Based Compensation393 M

Additional Tools for Medtronic Stock Analysis

When running Medtronic PLC's price analysis, check to measure Medtronic PLC's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medtronic PLC is operating at the current time. Most of Medtronic PLC's value examination focuses on studying past and present price action to predict the probability of Medtronic PLC's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medtronic PLC's price. Additionally, you may evaluate how the addition of Medtronic PLC to your portfolios can decrease your overall portfolio volatility.